S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later

Income Opportunity Realty Investors (IOR) Earnings Date, Estimates & Call Transcripts

$14.75
0.00 (0.00%)
(As of 02/26/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

IOR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IOR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

IOR Earnings Date and Information

Income Opportunity Realty Investors has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 21st, 2024 based off prior year's report dates.

Income Opportunity Realty Investors Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/21/2024
Estimated)
------- 
11/9/2023Q3 2023-$0.39+$0.39$0.39--
8/10/2023Q2 2023-$0.44+$0.44$0.44--
5/11/2023Q1 2023-$0.25+$0.25$0.25--
3/23/2023Q4 2022-$0.30+$0.30$0.30--
11/10/2022Q3 2022-$0.29+$0.29$0.29--
8/12/2022Q2 2022-$0.20+$0.20$0.20--
5/13/2022Q1 2022-$0.15+$0.15$0.15--
3/25/2022Q4 2021-$0.17+$0.17$0.17--
11/10/2021Q3 2021-$0.17+$0.17$0.17--
8/13/2021Q2 2021-$0.20+$0.20$0.20--
5/17/2021Q1 2021-$0.32+$0.32$0.32--
3/30/2021Q4 2020-$0.32+$0.32$0.32--












Income Opportunity Realty Investors Earnings - Frequently Asked Questions

When is Income Opportunity Realty Investors's earnings date?

Income Opportunity Realty Investors has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 21st, 2024 based off last year's report dates. Learn more on IOR's earnings history.

How much profit does Income Opportunity Realty Investors generate each year?

Income Opportunity Realty Investors (NYSEAMERICAN:IOR) has a recorded net income of $3.93 million. IOR has generated $1.38 earnings per share over the last four quarters.

What is Income Opportunity Realty Investors's price-to-earnings ratio?

Income Opportunity Realty Investors (NYSEAMERICAN:IOR) has a trailing price-to-earnings ratio of 10.69.


More Earnings Resources from MarketBeat

This page (NYSEAMERICAN:IOR) was last updated on 2/27/2024 by MarketBeat.com Staff